{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:01:45Z","timestamp":1792101705306,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fonds National de la Recherche Scientifique Belgium","award":["3.4.540.09.F"],"award-info":[{"award-number":["3.4.540.09.F"]}]},{"DOI":"10.13039\/100000073","name":"Autism Speaks","doi-asserted-by":"publisher","award":["8202"],"award-info":[{"award-number":["8202"]}],"id":[{"id":"10.13039\/100000073","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ymgme.2014.10.002","type":"journal-article","created":{"date-parts":[[2014,10,12]],"date-time":"2014-10-12T10:08:16Z","timestamp":1413108496000},"page":"307-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies"],"prefix":"10.1016","volume":"113","author":[{"given":"V.T.","family":"Ramaekers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5001-086X","authenticated-orcid":false,"given":"B.","family":"Th\u00f6ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Sequeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ansseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-9524","authenticated-orcid":false,"given":"F.","family":"Boemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bours","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.","family":"Quadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.10.002_bb0005","first-page":"1821","article-title":"Schizophrenia: a review","volume":"75","author":"Schultz","year":"2007","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ymgme.2014.10.002_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/bmj.39227.616447.BE","article-title":"Schizophrenia","volume":"335","author":"Picchioni","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ymgme.2014.10.002_bb0015","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1073\/pnas.201243998","article-title":"Mapping adolescent brain change reveals dynamic wave of accelerating grey matter loss in very early-onset schizophrenia","volume":"98","author":"Thompson","year":"2001","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.ymgme.2014.10.002_bb0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.31887\/DCNS.2006.8.3\/broth","article-title":"Contributions of molecular biology to antipsychotic drug discovery: promises fulfilled or unfulfilled?","volume":"8","author":"Roth","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ymgme.2014.10.002_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.mp.4001444","article-title":"The molecular genetics of schizophrenia: new findings promise new insights","volume":"9","author":"Owen","year":"2004","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.ymgme.2014.10.002_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.euroneuro.2007.06.005","article-title":"Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia","volume":"18","author":"Muntjewerff","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ymgme.2014.10.002_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S1092852900021015","article-title":"Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia","volume":"4","author":"Stahl","year":"2007","journal-title":"CNS Spectr."},{"issue":"5","key":"10.1016\/j.ymgme.2014.10.002_bb0040","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/schbul\/sbs076","article-title":"NMDA receptor and schizophrenia: a brief history","volume":"38","author":"Coyle","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.ymgme.2014.10.002_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2008.12.005","article-title":"Psychedelics and schizophrenia","volume":"32","author":"Gonz\u00e1lez-Maeso","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ymgme.2014.10.002_bb0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","article-title":"Mice with reduced NMDA receptor expression display behaviors related to schizophrenia","volume":"98","author":"Mohn","year":"1999","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ymgme.2014.10.002_bb0055","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1601-183X.2012.00816.x","article-title":"Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?","volume":"11","author":"Gandal","year":"2012","journal-title":"Genes Brain Behav."},{"issue":"4","key":"10.1016\/j.ymgme.2014.10.002_bb0060","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00415-010-5788-9","article-title":"Disease-relevant autoantibodies in first episode schizophrenia","volume":"258","author":"Zandi","year":"2011","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.ymgme.2014.10.002_bb0065","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/01.wnl.0000278388.90370.c3","article-title":"Anti-NMDA receptor encephalitis in Japan: long-term outcome with tumor removal","volume":"70","author":"Iizuka","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2014.10.002_bb0070","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ymgme.2014.10.002_bb0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-440X(97)90925-1","article-title":"Folate and cobalamin in psychiatric illness","volume":"38","author":"Hutto","year":"1997","journal-title":"Compr. Psychiatry"},{"issue":"7","key":"10.1016\/j.ymgme.2014.10.002_bb0080","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.pnpbp.2005.06.023","article-title":"Schizophrenia and single-carbon metabolism","volume":"29","author":"Regland","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ymgme.2014.10.002_bb0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0140-6736(90)91942-4","article-title":"Enhancement of recovery from psychiatric illness by methylfolate","volume":"336","author":"Godfrey","year":"1990","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ymgme.2014.10.002_bb0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM197503062921001","article-title":"Folate-responsive homocystinuria and \u201cschizophrenia\u201d. A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity","volume":"292","author":"Freeman","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.10.002_bb0095","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3111","article-title":"Inherited disorders of folate transport and metabolism","author":"Rosenblatt","year":"1995"},{"issue":"4","key":"10.1016\/j.ymgme.2014.10.002_bb0100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1096\/fasebj.10.4.8647346","article-title":"S-adenosylmethionine and methylation","volume":"10","author":"Chiang","year":"1996","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2014.10.002_bb0105","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1753-4887.2007.tb00281.x","article-title":"Identification of proton-coupled high-affinity human intestinal folate transporter mutated in human hereditary familial folate malabsorption","volume":"65","author":"Wolf","year":"2007","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ymgme.2014.10.002_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.nutr.19.1.91","article-title":"Carrier-mediated membrane transport of folates in mammalian cells","volume":"19","author":"Sirotnak","year":"1999","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.ymgme.2014.10.002_bb0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/bj2800267","article-title":"High affinity folate binding in human choroid plexus","volume":"280","author":"Holm","year":"1991","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.ymgme.2014.10.002_bb0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1469-8749.2004.tb00451.x","article-title":"Cerebral folate deficiency","volume":"46","author":"Ramaekers","year":"2004","journal-title":"Dev. Med. Child Neurol."},{"issue":"7","key":"10.1016\/j.ymgme.2014.10.002_bb0185","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1177\/0883073809343475","article-title":"Cerebral folate deficiency presenting as adolescent catatonic schizophrenia: a case report","volume":"25","author":"Ho","year":"2010","journal-title":"J. Child Neurol."},{"issue":"19","key":"10.1016\/j.ymgme.2014.10.002_bb0125","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa043160","article-title":"Autoantibodies to folate receptors in the cerebral folate deficiency syndrome","volume":"352","author":"Ramaekers","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.10.002_bb0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1515\/cclm-2012-0577","article-title":"The diagnostic utility of folate receptor autoantibodies in blood","volume":"51","author":"Sequeira","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2014.10.002_bb0135","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ejhg.2010.184","article-title":"Phenotypic manifestations of copy number variation in chromosome","volume":"19","author":"Nagamani","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.ymgme.2014.10.002_bb0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/bdra.10088","article-title":"Antibodies to folate receptors impair embryogenesis and fetal development in the rat","volume":"67","author":"Da Costa","year":"2003","journal-title":"Birth Defects Res. A Clin. Mol. Terat. l"},{"issue":"1","key":"10.1016\/j.ymgme.2014.10.002_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/dvdy.20107","article-title":"Embryonic development of folate binding protein-1 (Folbp1) knockout mice: effects of the chemical form, dose, and timing of maternal folate supplementation","volume":"231","author":"Spiegelstein","year":"2004","journal-title":"Dev. Dyn."},{"issue":"3","key":"10.1016\/j.ymgme.2014.10.002_bb0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/mp.2011.175","article-title":"Cerebral folate receptor autoantibodies in autism spectrum disorder","volume":"18","author":"Frye","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.ymgme.2014.10.002_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2002-37082","article-title":"Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low N5-methyltetrahydrofolate in cerebrospinal fluid","volume":"33","author":"Ramaekers","year":"2002","journal-title":"Neuropediatrics"},{"issue":"6","key":"10.1016\/j.ymgme.2014.10.002_bb0160","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-2008-1065354","article-title":"Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits","volume":"38","author":"Ramaekers","year":"2007","journal-title":"Neuropediatrics"},{"issue":"5","key":"10.1016\/j.ymgme.2014.10.002_bb0165","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1469-8749.2008.02053.x","article-title":"A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome","volume":"50","author":"Ramaekers","year":"2008","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2014.10.002_bb0170","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/dneu.21000","article-title":"Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders","volume":"72","author":"Schaevitz","year":"2012","journal-title":"Dev. Neurobiol."},{"issue":"9","key":"10.1016\/j.ymgme.2014.10.002_bb0175","doi-asserted-by":"crossref","first-page":"593","DOI":"10.5483\/BMBRep.2010.43.9.593","article-title":"Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr\u2212\/\u2212 mice: relevance to schizophrenia","volume":"43","author":"Choi","year":"2010","journal-title":"BMB Rep."},{"issue":"8","key":"10.1016\/j.ymgme.2014.10.002_bb0180","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1017\/S0007114514002116","article-title":"Folate deficiency in rat pups during weaning causes learning and memory deficits","volume":"112","author":"Berrocal-Zaragoza","year":"2014","journal-title":"Br. J. Nutr."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214003114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214003114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T16:52:06Z","timestamp":1650387126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214003114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1096719214003114"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.10.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}